# GPGI, Inc.: overview

GPGI · NYSE · CIK 1823144 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gpgi.md) · [Financials](/companies/gpgi/financials.md) · [Filings](/companies/gpgi/filings.md) · [Insiders](/companies/gpgi/insiders.md)

Latest reported revenue: [$0](/filings/0001628280-26-053968.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053968).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [107](/filings/0001823144-25-000125.md) | [101 d](/filings/0001628280-26-017266.md) | [59.8](/filings/0001628280-26-032173.md) | [0.0](/filings/0001628280-26-053968.md) | [0.0](/filings/0001823144-25-000125.md) | [0.0 d](/filings/0001628280-26-017266.md) | [0.0](/filings/0001628280-26-032173.md) | [0.0](/filings/0001628280-26-053968.md) |
| Gross margin | % | [51.7%](/filings/0001823144-25-000125.md) | [52.1% d](/filings/0001628280-26-017266.md) | [48.0%](/filings/0001628280-26-032173.md) | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [27.2%](/filings/0001823144-25-000125.md) | [15.5% d](/filings/0001628280-26-017266.md) | [10.0%](/filings/0001628280-26-032173.md) | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(39.3%)](/filings/0001823144-25-000125.md) | [(37.0%) d](/filings/0001628280-26-017266.md) | [36.0%](/filings/0001628280-26-032173.md) | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [(1.10)](/filings/0001823144-25-000125.md) | not reported | [0.07](/filings/0001628280-26-032173.md) | [(0.26)](/filings/0001628280-26-053968.md) | [(1.58)](/filings/0001823144-25-000125.md) | not reported | [(0.87)](/filings/0001628280-26-032173.md) | [0.17](/filings/0001628280-26-053968.md) |
| Free cash flow | $m | [27.8 d](/filings/0001823144-25-000125.md) | [31.5 d](/filings/0001628280-26-017266.md) | [3.0](/filings/0001628280-26-032173.md) | [0.0 d](/filings/0001628280-26-053968.md) | [(11.9) d](/filings/0001823144-25-000125.md) | [(14.0) d](/filings/0001628280-26-017266.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [268](/filings/0001823144-24-000002.md) | [378](/filings/0001823144-25-000004.md) | [391](/filings/0001628280-26-017266.md) | [421](/filings/0001628280-26-017266.md) | [59.8](/filings/0001628280-26-017266.md) |
| Gross margin | % | [54.1%](/filings/0001823144-24-000002.md) | [58.0%](/filings/0001823144-25-000004.md) | [53.5%](/filings/0001628280-26-017266.md) | [52.1%](/filings/0001628280-26-017266.md) | [48.1%](/filings/0001628280-26-017266.md) |
| Operating margin | % | [30.4%](/filings/0001823144-24-000002.md) | [30.4%](/filings/0001823144-25-000004.md) | [30.5%](/filings/0001628280-26-017266.md) | [25.6%](/filings/0001628280-26-017266.md) | [(23.0%)](/filings/0001628280-26-017266.md) |
| Net margin | % | [(26.3%)](/filings/0001823144-22-000005.md) | [4.9%](/filings/0001823144-25-000004.md) | [4.9%](/filings/0001628280-26-017266.md) | [(12.8%)](/filings/0001628280-26-017266.md) | [(227.3%)](/filings/0001628280-26-017266.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001823144-24-000002.md) | [1.13](/filings/0001823144-25-000004.md) | [0.96](/filings/0001628280-26-017266.md) | [(1.22)](/filings/0001628280-26-017266.md) | [(1.23)](/filings/0001628280-26-017266.md) |
| Free cash flow | $m | [73.0](/filings/0001823144-24-000002.md) | [83.7](/filings/0001823144-25-000004.md) | [93.4](/filings/0001628280-26-017266.md) | [122](/filings/0001628280-26-017266.md) | [(22.9)](/filings/0001628280-26-017266.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gpgi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Platinum Equity Advisors, LLC/DE](/funds/1803274.md) | 2026-06-30 | $837.4m | 52,829,757 |  | Unchanged |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $677.5m | 42,747,045 |  | Added +3,195,112 |
| [Alyeska Investment Group, L.P.](/funds/1453072.md) | 2026-06-30 | $371.0m | 23,404,836 |  | Added +2,009,583 |
| [LOCUST WOOD CAPITAL ADVISERS, LLC](/funds/1349434.md) | 2026-06-30 | $236.3m | 14,907,488 |  | Added +1,123,835 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $226.5m | 14,292,013 |  | Added +614,851 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $183.1m | 11,550,580 |  | Added +289,867 |
| [COOPERMAN LEON G](/funds/898382.md) | 2026-06-30 | $180.4m | 11,384,508 |  | New +11,384,508 |
| [BARROW HANLEY MEWHINNEY & STRAUSS LLC](/funds/313028.md) | 2026-06-30 | $165.5m | 10,439,933 |  | Added +4,838,428 |
| [CORSAIR CAPITAL MANAGEMENT, L.P.](/funds/1276470.md) | 2026-06-30 | $135.0m | 8,517,859 |  | Added +52,070 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $132.6m | 8,367,535 |  | Added +97,078 |

## Recent filings

[All 784 filings](/companies/gpgi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 09:23 ET | [10-Q](/filings/0001628280-26-053968.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053968 |
| 2026-08-06 | 07:03 ET | [8-K](/filings/0001628280-26-053821.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-053821 |
| 2026-06-12 | 16:12 ET | [8-K](/filings/0001628280-26-042849.md) | 5.07 Shareholder vote results | 0001628280-26-042849 |
| 2026-06-05 | 17:15 ET | [8-K](/filings/0001104659-26-071041.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-071041 |
| 2026-06-04 | 16:36 ET | [8-K](/filings/0001628280-26-040851.md) | 5.07 Shareholder vote results | 0001628280-26-040851 |
| 2026-05-07 | 16:22 ET | [10-Q](/filings/0001628280-26-032173.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032173 |
| 2026-05-07 | 07:15 ET | [8-K](/filings/0001628280-26-031681.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-031681 |
| 2026-04-24 | 16:13 ET | [DEF 14A](/filings/0001104659-26-048561.md) | Proxy statement, period 2026-06-11 | 0001104659-26-048561 |
| 2026-04-20 | 16:25 ET | [DEF 14A](/filings/0001104659-26-045522.md) | Proxy statement, period 2026-06-04 | 0001104659-26-045522 |
| 2026-03-16 | 08:00 ET | [8-K](/filings/0001104659-26-028021.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-028021 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-017266.md), filed Mar 12, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/de6da825-639b-4bf7-8418-98980d172057)

## About the filer

- CIK: 1823144
- Tickers: GPGI
- Exchange: NYSE
- SIC code: 6199 Finance Services
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.